Laddar...
[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
In the United States, [(68)Ga]Ga-DOTA-TOC has been approved by the Food and Drug Administration (FDA) in 2019 as the first (68)Ga-radiopharmaceutical for imaging of somatostatin receptor (SSTR) positive gastroenteropancreatic neuroendocrine tumors while employing positron emission tomography (PET)....
Sparad:
| I publikationen: | Pharmaceuticals (Basel) |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7151717/ https://ncbi.nlm.nih.gov/pubmed/32138377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13030038 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|